Filtrar por género

NeurologyLive® Mind Moments®

NeurologyLive

Mind Moments®, a podcast from NeurologyLive® (https://www.neurologylive.com/) , brings you exclusive interviews with experts in neurologic disorders. Listen in to hear the latest clinical and research updates from major medical conferences, as well as insights on the management of complex disorders, including epilepsy, migraine, Alzheimer disease, stroke, multiple sclerosis, Parkinson disease, and more. For more expert insight into neurology, visit NeurologyLive.com (https://www.neurologylive.com/) .

124 - 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia

0:00 / 0:00

124 - 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia
Fri, 05 Apr 2024
123 - Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy
Fri, 29 Mar 2024
122 - 111: Reviewing ACTRIMS 2024
Fri, 22 Mar 2024
121 - 110: Differential Diagnosis of Sleep Disorders and Hypersomnias
Fri, 08 Mar 2024
120 - 109: AB126, Exosomes, and Cerebroprotection for Stroke
Fri, 23 Feb 2024
119 - 108: Advancing the Genetic Pool of Parkinson Disease
Fri, 09 Feb 2024
118 - 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers
Fri, 26 Jan 2024
117 - 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis
Fri, 12 Jan 2024
116 - 105: Recapping Conversations in Neurology From 2023
Fri, 29 Dec 2023
115 - 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2
Fri, 15 Dec 2023
114 - 103: Advancing Epilepsy Care and Seizure Localization in Pediatrics
Fri, 01 Dec 2023
113 - 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease
Fri, 17 Nov 2023
112 - Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy
Tue, 07 Nov 2023
111 - 101: Ways to Enhance Neuromodulation in Parkinsonism
Fri, 03 Nov 2023
110 - Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis
Mon, 23 Oct 2023
109 - 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights
Fri, 20 Oct 2023
108 - 99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy
Thu, 05 Oct 2023
107 - 98: Uncovering Phenotypical Features of Narcolepsy Type 1
Fri, 22 Sep 2023
106 - 97: Identifying Gaps in Access to Parkinson Disease Care
Fri, 08 Sep 2023
105 - 96: Complexities With Cognitive Screening in Primary Care Settings
Fri, 25 Aug 2023
104 - Special Episode: Addition of Valbenazine to Treat Huntington Disease Chorea
Mon, 21 Aug 2023
103 - 95: Expanding Potential for Long-Term Treatment in SMA
Fri, 11 Aug 2023
102 - 94: The Discussion Surrounding Lecanemab's Approval for Alzheimer Disease
Fri, 28 Jul 2023
101 - 93: Caring for Women With Parkinson Disease
Fri, 14 Jul 2023
100 - 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
Fri, 30 Jun 2023
99 - Special Episode: SRP-9001 Approved As First Gene Therapy for Duchenne Muscular Dystrophy
Thu, 22 Jun 2023
98 - 91: Assessing the Landscape of Sleep Disorder Care
Fri, 16 Jun 2023
97 - 90: Raising Stroke Awareness and Improving Clinical Care
Fri, 02 Jun 2023
96 - 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS
Fri, 19 May 2023
95 - 88: 2023 AAN Annual Meeting Highlights
Fri, 05 May 2023
94 - Special Episode: Tofersen Approved for SOD1 ALS
Tue, 25 Apr 2023
93 - 87: Severe Multiple Sclerosis and the CASA-MS Study
Fri, 21 Apr 2023
92 - 86: Pimavanserin and Atypical Antipsychotics to Treat Parkinson Disease Psychosis
Fri, 07 Apr 2023
91 - 85: Impact of Narcolepsy on Social Relationship Health in Adolescents
Fri, 24 Mar 2023
90 - Special Episode: Trofinetide Approved for Rett Syndrome
Mon, 13 Mar 2023
89 - 84: Parkinson Disease Education for Community Providers
Fri, 10 Mar 2023
88 - 83: The ARISE Study and Using DMTs in RIS
Fri, 24 Feb 2023
87 - 82: Managing Seizures After Ischemic Stroke
Fri, 10 Feb 2023
86 - 81: Widening the Therapeutic Window in Parkinson Disease
Fri, 27 Jan 2023
85 - 80: Advancing Treatment for Rare Neuromuscular Disorders
Fri, 13 Jan 2023
84 - Special Episode: Lecanemab Approved for Alzheimer Disease
Mon, 09 Jan 2023
83 - 79: A New Monoclonal for Alzheimer Disease
Fri, 16 Dec 2022
82 - 78: A Virtual Reality Platform for Parkinson Disease
Fri, 02 Dec 2022
81 - 77: A New Era of Myasthenia Gravis Treatment
Fri, 18 Nov 2022
80 - 76: ECTRIMS 2022 and the Latest in MS Advances
Fri, 04 Nov 2022
79 - 75: Focusing on the Future of Neurology
Fri, 21 Oct 2022
78 - 74: Prescription Digital Therapeutics for Insomnia
Fri, 07 Oct 2022
77 - 73: The Role of Palliative Care in Neurology
Fri, 23 Sep 2022
76 - 72: Updates in Epilepsy Treatment
Fri, 09 Sep 2022
75 - 71: Pediatric Sleep and School Start Times
Fri, 26 Aug 2022
74 - 70: Raising Awareness of Acute Flaccid Myelitis
Fri, 12 Aug 2022
73 - 69: The Widespread Effects of DMT Waste in Multiple Sclerosis
Fri, 29 Jul 2022
72 - 68: Updates in Essential Tremor Care
Fri, 15 Jul 2022
71 - 67: Mental Health and Advocacy in Pediatric Migraine
Fri, 01 Jul 2022
70 - 66: 2022 SLEEP Annual Meeting Highlights
Fri, 17 Jun 2022
69 - Special Episode: Aducanumab and Anti-Amyloid-ß, One Year Later
Tue, 07 Jun 2022
68 - 65: 2022 CMSC Annual Meeting Highlights
Sat, 04 Jun 2022
67 - 64: Genetics, Advocacy, and Big Data in ALS
Fri, 20 May 2022
66 - 63: Moving Migraine Toward Personalized Care
Fri, 06 May 2022
65 - 62: Advanced Therapeutics in Parkinson and Movement Disorders
Fri, 22 Apr 2022
64 - 61: 2022 AAN Annual Meeting Highlights
Sat, 09 Apr 2022
63 - Special Episode: Ganaxolone Approved for CDD, Fenfluramine Approved for LGS
Wed, 30 Mar 2022
62 - 60: Improving Care and Raising Awareness for NMOSD
Fri, 25 Mar 2022
61 - Special Episode: Heart Health in Narcolepsy
Fri, 18 Mar 2022
60 - 59: AASM's Push to End Daylight Saving Time
Fri, 11 Mar 2022
59 - 58: Addressing Parkinson Disease Virtually With Prime PD
Fri, 25 Feb 2022
58 - 57: Invisible Symptoms: Cognition and MS
Fri, 11 Feb 2022
57 - 56: Epstein-Barr Virus's Relationship With Multiple Sclerosis
Fri, 28 Jan 2022
56 - 55: Treating Headache in the Emergency Department
Fri, 14 Jan 2022
55 - Special Episode: Daridorexant Approved for Insomnia
Tue, 11 Jan 2022
54 - 54: The Shortage of Neurologists
Fri, 31 Dec 2021
53 - 53: A Landmark Year for Alzheimer Disease
Fri, 17 Dec 2021
52 - 52: Treating Pediatric Migraine
Fri, 03 Dec 2021
51 - 51: The State of Sleep Medicine
Fri, 19 Nov 2021
50 - 50: Genetic Testing for Huntington Disease
Fri, 05 Nov 2021
49 - 49: Altering the View of MS With a Topographical Model
Fri, 22 Oct 2021
48 - 48: RapidAI's Effect on Stroke Imaging
Fri, 08 Oct 2021
47 - 47: Incorporating Physical Therapy Into MS Care
Fri, 24 Sep 2021
46 - 46: Tackling Barriers to Migraine Care
Fri, 10 Sep 2021
45 - 45: Small Victories: Advancing Care in Parkinson Disease
Fri, 27 Aug 2021
44 - 44: AHA/ASA Updates to the Stroke Care Model
Fri, 13 Aug 2021
43 - 43: Is Telehealth Here to Stay for Alzheimer Disease Care?
Fri, 30 Jul 2021
42 - 42: The Importance of Sleep for Overall Health
Fri, 16 Jul 2021
41 - 41: Consensus MRI Guidelines for MS
Fri, 02 Jul 2021
40 - 40: SLEEP 2021: Topline Data, Telemedicine, and Takeaways
Fri, 18 Jun 2021
39 - 39: A Controversial FDA Decision
Fri, 11 Jun 2021
38 - 38: Advancing MS Care and Awareness
Fri, 04 Jun 2021
37 - 37: The Impact of Awareness Efforts in ALS
Fri, 21 May 2021
36 - 36: Zavegepant and the Gepant Class for Migraine Care
Fri, 07 May 2021
35 - 35: Highlights From the AAN Annual Meeting
Fri, 30 Apr 2021
34 - 34: Hope and the Huntington Disease Pipeline
Fri, 23 Apr 2021
33 - 33: Problem Recognition: Cerebral Palsy Diagnosis
Fri, 09 Apr 2021
32 - 32: The Gaps in Migraine Care for Women
Fri, 26 Mar 2021
31 - 31: The Pipeline Pendulum in Parkinson Disease
Fri, 12 Mar 2021
30 - 30: Cognitive Behaviorial Therapy for Insomnia
Fri, 26 Feb 2021
29 - 29: Developing A Seizure Action Plan
Fri, 12 Feb 2021
28 - 28: The Multiple Sclerosis Patient Journey
Fri, 29 Jan 2021
27 - 27: Short, Sudden, Strange, Similar Spells
Fri, 15 Jan 2021
26 - 26: Digital Approaches to Comprehensive Care in MS
Fri, 01 Jan 2021
25 - 25: 2020 Wrap Up: Silver Linings
Thu, 31 Dec 2020

Mostrar más episodios

Filtrar por género

NeurologyLive® Mind Moments®

Podcasts similares a NeurologyLive® Mind Moments®